This interview with an EU based KOL provides detailed insights into the current atopic dermatitis treatment landscape and future therapy expectations. The discussion covers real?world use of biologics and JAK inhibitors, unmet needs in disease control, and views on emerging mechanisms.

This interview was conducted on October 03, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.